Roselabs Finance Ltd
BSE:531324
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Roselabs Finance Ltd
BSE:531324
|
IN |
|
CareView Communications Inc
OTC:CRVW
|
US |
Balance Sheet
Balance Sheet Decomposition
Roselabs Finance Ltd
Roselabs Finance Ltd
Balance Sheet
Roselabs Finance Ltd
| Mar-2007 | Mar-2008 | Mar-2009 | Mar-2010 | Mar-2021 | Mar-2022 | Mar-2023 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
2
|
2
|
1
|
14
|
1
|
0
|
0
|
|
| Cash |
2
|
2
|
1
|
14
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Receivables |
56
|
76
|
84
|
126
|
0
|
0
|
0
|
|
| Accounts Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
55
|
76
|
84
|
126
|
0
|
0
|
0
|
|
| Inventory |
15
|
9
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
3
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Total Current Assets |
75
|
88
|
87
|
141
|
1
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Long-Term Investments |
13
|
0
|
0
|
4
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
12
|
13
|
18
|
22
|
1
|
1
|
1
|
|
| Total Assets |
100
N/A
|
101
+0%
|
104
+4%
|
167
+60%
|
2
-99%
|
2
-14%
|
1
-39%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
46
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
0
|
15
|
16
|
1
|
|
| Total Current Liabilities |
0
|
0
|
1
|
1
|
61
|
16
|
1
|
|
| Long-Term Debt |
0
|
0
|
3
|
65
|
0
|
49
|
43
|
|
| Total Liabilities |
0
N/A
|
0
-50%
|
4
+3 700%
|
66
+1 645%
|
61
-8%
|
65
+7%
|
44
-32%
|
|
| Equity | ||||||||
| Common Stock |
100
|
100
|
100
|
100
|
100
|
100
|
100
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
159
|
163
|
143
|
|
| Total Equity |
100
N/A
|
100
+0%
|
100
N/A
|
100
N/A
|
59
N/A
|
63
-7%
|
43
+32%
|
|
| Total Liabilities & Equity |
100
N/A
|
101
+0%
|
104
+4%
|
167
+60%
|
2
-99%
|
2
-14%
|
1
-39%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
10
|
10
|
10
|
10
|
10
|
10
|
10
|
|